Position Overview:
As the Value and Partnerships Senior Manager you will be responsible for leading strategic market access initiatives that help sustain market leadership for Insulet’s products and deliver both improved outcomes for people with diabetes and continued growth.
This will be achieved through directing how the value proposition for Omnipod is strengthened, differentiated and leveraged and through sourcing and securing strategic partnerships at national or regional level that drive mutual value.
Reporting to the Head of Market Access for UK/Benelux, you will collaborate with both commercial and clinical leadership within Insulet to create momentum for change in health systems that promotes the advance of technology.
You will be responsible for plans that align with both the long and short term goals of the organisation and maintain both a short and longer-term perspective yourself. You will be comfortable with engaging customers at a senior level and functioning as a trusted partner.
Key Responsibilities:
Required Skills and Competencies:
Education and Experience:
Additional Information:
This is a field-based role working across the entirety of the UK and Benelux areas. The successful candidate will need to be able to travel across this region as well as occasional travel to Insulet’s UK/Benelux head office in West London.
Physical Requirements: Travel up to 50% as required.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us here.